Combined use of G-CSF with angiogenetic factor
Details for Australian Patent Application No. 2004222451 (hide)
International Classifications
Event Publications
20 October 2005 PCT application entered the National Phase
PCT publication WO2004/082703 Priority application(s): WO2004/082703
27 November 2008 Amendment Made
The nature of the amendment is: Amend the invention title to read from Combined use of G-CSF with angiogenetic factor to Combined use of G-CSF and factors having angiogenic action
15 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004222460-Blood treatment device and method with selective solute extraction
2004222442-Patch containing nonsteroidal antiinflammatory and analgesic agent
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional

- Editable Word format reports
- For IP Professionals
- Multiuser